Arkolith/Insider Trading/AXSM/Form 4

Saad Mark E

DirectorAxsome Therapeutics, Inc. (AXSM) · full profile →Form 4 · filed Jan 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$6.2M
Net Open-Market Flow
-$6.2M
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)6K$8.02$50K16K
Dec 31, 2025Sell(S)6K$165.18$1.0M10K
Dec 31, 2025Sell(S)31K$165.18$5.2M10K
Dec 31, 2025Option exercise(M)31K$4.95$155K41K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 31, 2025Option exercise(M)6K—$00
Dec 31, 2025Option exercise(M)31K—$00

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-001181) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML